Overview Titratable Dosing in Moderate to Severe Asthmatics Status: Completed Trial end date: 2005-01-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the long term safety of Symbicort with budesonide alone, in adolescents and adults with asthma. Phase: Phase 3 Details Lead Sponsor: AstraZenecaTreatments: BudesonideBudesonide, Formoterol Fumarate Drug CombinationFormoterol Fumarate